top of page

CDC Health Alert: Severe Illness Potentially Associated with Consuming Diamond ShruumzTM Brand Chocolate Bars, Cones, and Gummies



The Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), America’s Poison Centers, and state and local partners are investigating reports of severe acute illnesses potentially associated with consuming Diamond ShruumzTM brand chocolate bars, cones, and gummies marketed as containing a proprietary blend of mushroom. As of June 11, 2024, 12 total illnesses and 10 hospitalizations have been reported in eight U.S. states with ongoing efforts to identify other potential cases. The cause of the reported illnesses is not known at this time. Individuals should not eat, sell, or serve any flavors of Diamond ShruumzTM brand chocolate bars, cones, or gummies, and should discard products that have been purchased. CDC and FDA are working to determine whether other products from this company are associated with adverse health effects.

Recommendations for the Public

  • Do not buy, eat, sell, or serve Diamond ShruumzTM brand chocolate bars, cones, or gummies. Discard and destroy any product that has been purchased.

  • Do not consume chocolate, gummies, snack foods, or other edible products claiming to produce feelings of euphoria, hallucinations, or psychedelic effects. They might contain undisclosed ingredients that might be linked to severe illness.

  • Store edibles and other products that contain mushrooms, THC, or CBD safely away from children. Children may mistake some edibles for candy.

  • Seek immediate medical attention or call the Poison Help Line (1-800-222-1222) for advice if you have consumed a product and are having symptoms. Signs and symptoms may include gastrointestinal effects (nausea, vomiting, abdominal pain), hallucinations, uncontrolled movements, fast or slow heart rate, high or low blood pressure, coughing, choking, excessive sweating or secretions, and flushed skin. Other severe adverse effects have been reported, including seizures, decreased level of consciousness, and respiratory failure.

  • Consumers are also encouraged to report adverse events related to these products to FDA MedWatch

Per FDA:



bottom of page